Jeanne Erdmann is an award-winning health and science writer based in Wentzville, Mo. A member of Association of
Health Care Journalists board of directors, she is the chair of the organization’s Freelance Committee. Her work has appeared in Discover, Women’s Health, Aeon, Slate, The Washington Post, Nature, Nature Medicine and other publications. You can follow her at @jeanne_erdmann.
Jeanne Erdmann
From this contributor
Analysis pins down prevalence of mental health conditions in autism
Eight mental health conditions occur unusually often in autistic people, a new analysis suggests.
Analysis pins down prevalence of mental health conditions in autism
By
Jeanne Erdmann
7 October 2019 | 2 min read
Drug screen reveals potential treatments for Rett syndrome
An experimental leukemia drug and a chemical in black pepper ease breathing and movement problems in a mouse model of Rett syndrome.
Drug screen reveals potential treatments for Rett syndrome
By
Jeanne Erdmann
11 September 2019 | 4 min read
Explore more from The Transmitter
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
By
Jill Adams
15 September 2026 | 2 min read
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
By
Katie Moisse
15 September 2026 | 8 min read
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.
By
Paige Miranda
15 September 2026 | 0 min watch